arrow_right
For Patients
FOR PATIENTS
The Envisia classifier is a new genomic test that aids your physician in differentiating between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD), without having to do a surgical lung biopsy.
It is currently available at select U.S. institutions listed below.•

Please note that the ILD experts in each practice will conduct a clinical evaluation which may or may not involve the use of Envisia classifier. It will be up to the clinical judgment of the physician to determine the appropriate diagnostic workup.

Contact Veracyte Client Services by phone at 844.464.LUNG (5864) or support@veracyte.com.
Search for institutions offering Envisia Testing
DOWNLOAD PATIENT HANDOUT
CONTACT A REP TO ORDER VERACYTE TESTING
Veracyte representatives are happy to assist you and to discuss how to integrate our tests into your practice.
First Name
Last Name
Email
Institution
Zip Code
Which Test Interests You?
More About You
Message
CONTACT REP
* This list will be updated as the test becomes available at more institutions.
© 2019 Veracyte, Inc. All rights reserved.